Developing a Blended diet guideline Developing Blended Diet Guideline

This webinar had the focus on the use of fibre supplements' in the nutritional management of patients with acute illness. The speaker, Nirouz Zarroug, discussed the impact of clinical decisions related to patient care.

A multi-centre, single arm study designed to evaluate the gastro-intestinal tolerance and compliance of a standard adult enteral tube feed with food derived ingredients in the United Kingdom. Objective The primary objective of the study was to assess the tolerability, acceptability of a whole-protein 1.1 kcal/mL enteral tube feed containing 16% of food derived ingredients and assessing compliance with the new tube feed. Secondary objectives included assessing reported changes to feed tolerance, compliance and a patient satisfaction. Results The tolerance study took place between January 2023 to January 2024 where 16/17 participants completed 7 days. No serious adverse events reported. Majority of the participant in the study have neurological conditions such as cerebral palsy, learning difficulties, stroke and brain injury. Male to female ratio was 11:6. Average age 28 years, the youngest being 8 years and 2 months and the eldest 71 years of age. Average weight 41 kg, height 1.39 meters and average BMI 21 kg.m2. Average volume consumed was 877mLs versus 929mLs prescribed by the dietitians with a compliance rate of 94%. Conclusion Compleat® 1.1 kcal/mL was well tolerated by majority of patients, with some experiencing improvements in stool type and consistency. Two participants did experience flatulence and one with additional abdominal pain due to the fibre content in the new trial feed. Suggest a slower infusion for those patients sensitive to fibre. For more information on the product please visit Compleat® 1.1 | Nestlé Health Science

METHOD A prospective, singlearm multicentre study was carried out to assess GI tolerance and compliance to a new formula, Peptamen HN PHGG®. Participants were under the care of a Dietitian and recruited from two NHS settings. Participants were adults who were tube fed, receiving >60% of their estimated requirements enterally, experiencing GI discomfort (diarrhoea, constipation, excessive wind or nausea) and able to consent. RESULTS 21 participants (30–88 years), identified by Dietitians as meeting inclusion criteria, were consented and enrolled; 13 participants had completed the trial at the time of writing. Primary diagnoses included oesophageal cancer, GI tract surgery, pancreatitis, aspergilloma, EhlersDanlos, and myasthenia gravis. Four participants were fed into the stomach and nine into the jejunum. All patients began the trial due to diarrhoea. At baseline, 92% (n=12) had a type 6 or 7 stool; one patient had an ileostomy reporting diarrhoea. At the end of the study, 77% (n=10) reported a type 4 or 5 stool, with only 23% (n=3) still reporting type 6 or 7. Average stool frequency decreased from 2.9 to 2.3 per day. 77% (n=10) reported improved tolerance after starting the formula. 92% (n=12) tolerated the prescribed volume; 54% (n=7) tolerated a higher volume compared to their previous feed. CONCLUSIONS Tubefeed tolerance remains a challenge. Historically, Dietitians have needed to choose between a semielemental peptidebased feed or a fibre feed. This study shows Peptamen HN PHGG® was well tolerated by most participants, with reductions in undesirable GI symptoms, improvements in stool frequency and type, increased compliance, and high satisfaction levels.

Watch the impact of an enteral tube feed containing food-derived ingredients on symptom control after traumatic brain injury. Switching to an enteral tube feed with food-derived ingredients improved Patient Y’s symptoms, meaning she is able to remain cared for in the community without acute illness or infection.

Watch an enteral tube feed containing food-derived ingredients improve symptoms of nausea, vomiting and poor stool quality. Switching to an enteral tube feed containing food-derived ingredients improved Patient Z’s symptom management and helped her meet her nutritional requirements.

Watch if an enteral tube feed containing food-derived ingredients can improve both the physical health and mental wellbeing of an adult patient. Switching to an enteral tube feed containing food-derived ingredients helped Patient X’s physical health and management, and resulted in great psychological benefits.

This year's Nutrition and Hydration week will take place from the 16th to the 22nd of March. The week is designed to highlight the importance of adequate hydration and nutrition and how to support patients In achieving this.Malnutrition and dehydration are common complications of dysphagia. This Poster Pack is designed to support you in improving the nutrition and hydration status of dysphagia patients.

This year's Nutrition and Hydration week will take place from the 16th to the 22nd of March. The week is designed to highlight the importance of adequate hydration and nutrition and how to support patients in achieving this.The Global Tea Party is a highlight of Nutrition and Hydration Week. Support people with dysphagia to safely enjoy shared moments, with dysphagia-appropriate tea-party recipes.

Take the quiz

Watch this on-demand webinar: “Eating and Drinking with Acknowledged Risk in Practice: A clinical journey through an EDAR case study”. Expert speakers, Charles Douthwaite, Speech and Language Therapist (SLT) and Co-Owner of Excel SLT, and Hannah Plant, Specialist Neurology Dietitian, talk us through an insightful session, followed by an excellent Q and A. They covered:1. Patient Background: Medical history, social context, PEG placement rationale, and impaired swallow function.2. SLT Input: Swallow assessments, therapy attempts, and outcome measures.3. EDAR Framework: Introduction to EDAR, application to this case, and considerations for patients lacking capacity.4. Legal Context: Overview of the JJ vs Spectrum (2023) case and its implications for practice.5. MDT Process: Best interests meetings, risk analysis, and team collaboration in the care plan.6. Ongoing Management: Monitoring, risk review, and feed adjustments based on clinical changes.

Human milk contains bioactive components that confer protection on the newborn. These include complex carbohydrates called Human Milk Oligosaccharides (HMO). Research is revealing the full extent of the beneficial properties of HMOs.

Human milk contains bioactive components that confer protection on the newborn. These include complex carbohydrates called Human Milk Oligosaccharides (HMO). Research is revealing the full extent of the beneficial properties of HMOs.